STOCK TITAN
  1. Home
  2. News
  3. KRMD

KORU Medical Systems, Inc. - KRMD STOCK NEWS

Welcome to our dedicated page for KORU Medical Systems news (Ticker: KRMD), a resource for investors and traders seeking the latest updates and insights on KORU Medical Systems stock.

KORU Medical Systems, Inc. (symbol: KRMD) is a prominent developer and manufacturer of innovative medical devices and supplies, headquartered at 24 Carpenter Road, Chester, New York, United States. Specializing in mechanical infusion products, the company is renowned for its cutting-edge FREEDOM Infusion Systems. These systems include the FREEDOM60 and FreedomEdge Syringe Drivers, designed to provide efficient and reliable delivery of life-saving therapies.

KORU Medical Systems primarily focuses on subcutaneous infusion devices, which are essential for administering immunoglobulin therapies to patients suffering from chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Their product line features the Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets, enhancing the safety and effectiveness of home-based treatments.

The company's commitment to quality and innovation has positioned it as a leader in the medical device industry. Recent achievements include advancements in product technology and expanded partnerships aimed at enhancing patient care and expanding market reach. KORU Medical Systems continues to prioritize patient-centered solutions, ensuring their products meet the highest standards of safety and performance.

News

KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023

Rhea-AI Summary
KORU Medical Systems will report its third quarter 2023 financial results on November 8, 2023. The company will host a conference call and webcast to discuss the results and provide a corporate update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.86%
Tags
conferences earnings
-
News

KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference

Rhea-AI Summary
KORU Medical Systems to present two abstracts at the Immunoglobulin National Society 2023 National Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
conferences
-
News

KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors

Rhea-AI Summary
KORU Medical Systems appoints Edward Wholihan to its Board of Directors, bringing over 25 years of experience as CFO in the life sciences and healthcare sectors. His insights are expected to contribute to the company's future growth and success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
management
News

KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase

Rhea-AI Summary
KORU Medical Systems to participate in Gilmartin Group Emerging Growth Company Showcase on September 21, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
conferences acquisition
-
News

KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.22%
Tags
earnings
-
News

KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.87%
Tags
conferences
News

KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.82%
Tags
earnings
-
News

KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023

Rhea-AI Summary
KORU Medical Systems will report its second quarter 2023 financial results on August 9, 2023. A conference call and webcast will be held to discuss the financial results and provide a corporate update.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.12%
Tags
conferences earnings
-
News

KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic

Rhea-AI Summary
KORU Medical Systems has announced an agreement with a biopharmaceutical company to validate its FREEDOM Infusion System for use with a novel biologic drug. The drug developer is expected to begin Phase III studies by the end of 2023 for the treatment of a rare genetic disease. This collaboration adds to KORU Medical's existing partnerships for Phase II and Phase III studies of treatments in various medical fields.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none
News

KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes

Rhea-AI Summary
KORU Medical Systems, Inc. has submitted a 510(k) premarket notification submission to the FDA for the use of its FREEDOM60® Infusion System with Hizentra® 50 mL prefilled syringes. The company aims to simplify subcutaneous therapy for patients and improve their quality of life. The submission is expected to reduce drug preparation tasks by up to 80% for patients using prefilled syringes with the FREEDOM™ Infusion System. The FDA approved the 50 mL Hizentra prefilled syringe in April 2023, making it the most prescribed subcutaneous immunoglobulin available in prefilled syringes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.7%
Tags
none

FAQ

What is the current stock price of KORU Medical Systems (KRMD)?

The current stock price of KORU Medical Systems (KRMD) is $4.09 as of January 22, 2025.

What is the market cap of KORU Medical Systems (KRMD)?

The market cap of KORU Medical Systems (KRMD) is approximately 187.9M.

What does KORU Medical Systems, Inc. specialize in?

KORU Medical Systems specializes in developing and manufacturing mechanical infusion products, particularly the FREEDOM Infusion Systems.

Where is KORU Medical Systems, Inc. located?

The company is based at 24 Carpenter Road, Chester, New York, United States.

What are the primary products of KORU Medical Systems?

The primary products include the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets.

Who benefits from KORU Medical Systems' products?

Patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) benefit from their products.

What recent achievements has KORU Medical Systems accomplished?

Recent achievements include technological advancements in product development and expanding partnerships to enhance patient care and market reach.

What is the FREEDOM Infusion System?

The FREEDOM Infusion System is a mechanical infusion device designed to deliver immunoglobulin therapies efficiently and safely.

Why is KORU Medical Systems considered a leader in the industry?

The company is recognized for its commitment to quality, innovation, and patient-centered solutions in the medical device industry.

What is the focus of KORU Medical Systems' product development?

Their product development focuses on creating subcutaneous infusion devices for home-based treatments.

How does KORU Medical Systems ensure product safety?

The company ensures product safety by maintaining high standards in their design and manufacturing processes.

What kind of partnerships has KORU Medical Systems established?

They have established partnerships aimed at improving patient care services and expanding their market presence.
Stock KRMD logo
KORU Medical Systems, Inc.

Nasdaq:KRMD

KRMD Rankings

#3966 Ranked by Market Cap
N/A Ranked by Dividends

KRMD Stock Data

187.93M
42.58M
6.3%
54.38%
1.06%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
MAHWAH